Clinical trial
Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI
NCT00243152 · Pain and Analgesia Imaging and Neuroscience Group, Other · Completed
Key facts
| NCT number | NCT00243152 |
|---|---|
| Title | Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI |
| Official title | Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRI |
| Lead sponsor | Pain and Analgesia Imaging and Neuroscience Group, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Facial Neuropathy |
| Intervention type | Drug |
| Interventions | Lamotrigine, Placebo (for Lamotrigine) |
| Enrollment | 6 |
| Start date | Oct 1, 2005 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Oct 21, 2005 |
| Last update posted | Dec 7, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: